Samsa G P, Matchar D B
Center for Clinical Health Policy Research, Department of Medicine, Department of Community and Family Medicine, Duke University Medical Center, Durham, NC 27705, USA.
J Thromb Thrombolysis. 2000 Apr;9(3):283-92. doi: 10.1023/a:1018778914477.
Patient self-management (PSM) of anticoagulation, which is primarily based upon the premise that more frequent testing will lead to tighter anticoagulation control and thus to improved clinical outcomes, is a promising model of care. The goals of this paper are (1) to describe the strength of evidence correlating more frequent testing with improved outcomes; and (2) to discuss implications of these findings for the design of randomized controlled trials (RCTs) assessing the effectiveness and cost-effectiveness of PSM.
We performed two literature reviews: one examining the strength of the relationship between time in target range (TTR) and the clinical outcomes of major bleeding and thromboembolism; and the second examining the strength of the relationship between frequency of testing and TTR.
We found that (1) the relationship between TTR and clinical outcomes is strong, thus supporting use of TTR as a primary outcome variable; and (2) more frequent testing seems to increase TTR, although the studies supporting this latter conclusion were relatively few and not definitive. Statistical analysis suggested that a study which uses clinical event rates as its primary outcome would need to be much larger than a comparable study which is based upon TTR.
When designing randomized trials of PSM, the design should (1) use as its control group high quality anticoagulation management rather than usual care; (2) include the maximum possible amount of self-management in the intervention group; (3) include different testing intervals in the intervention group; (4) use TTR as the primary outcome variable and event rates as a secondary outcome; and (5) base the sample size calculations upon a 5-10% absolute improvement in TTR. Additional RCTs are needed in order to determine how the promise of PSM can best be fulfilled.
抗凝治疗的患者自我管理(PSM)是一种很有前景的护理模式,其主要前提是更频繁的检测将导致更严格的抗凝控制,从而改善临床结局。本文的目的是:(1)描述更频繁检测与改善结局之间相关证据的强度;(2)讨论这些发现对评估PSM有效性和成本效益的随机对照试验(RCT)设计的影响。
我们进行了两项文献综述:一项研究目标范围内时间(TTR)与大出血和血栓栓塞临床结局之间关系的强度;另一项研究检测频率与TTR之间关系的强度。
我们发现:(1)TTR与临床结局之间的关系很强,因此支持将TTR用作主要结局变量;(2)更频繁的检测似乎会增加TTR,尽管支持后一结论的研究相对较少且不明确。统计分析表明,以临床事件发生率作为主要结局的研究需要比基于TTR的可比研究大得多。
在设计PSM的随机试验时,设计应:(1)将高质量抗凝管理而非常规护理用作对照组;(2)在干预组中纳入尽可能多的自我管理;(3)在干预组中纳入不同的检测间隔;(4)将TTR用作主要结局变量,将事件发生率用作次要结局;(5)根据TTR绝对改善5%-10%来计算样本量。需要进行更多的RCT,以确定如何最好地实现PSM的前景。